Home » Newsletters » BioWorld

BioWorld

Oct. 16, 1996

View Archived Issues

CDR THERAPEUTICS AIMS TO DEVELOP SMALL MOLECULES THAT MIMIC LARGER

ENZON SIGNS EUROPEAN MARKETING PARTNER FOR ONCASPAR

INCYTE MAKES SECOND TECHNOLOGY ACQUISITION IN THREE WEEKS

OTHER NEWS TO NOTE

`SURPRISE' SWITCHABLE RIBOZYMES COULD ENHANCE GENE THERAPIES

GENENTECH PLANS TO TAKE NERVE GROWTH FACTOR INTO PHASE III

ARES-SERONO'S GROWTH HORMONE SAIZEN FINALLY CLEARED IN U.S.